Fox Chase Cancer Center and Brazilian Hospital Agree to Partner Expertise
PHILADELPHIA (October 19, 1999) -- Leaders from Fox Chase Cancer Center and Hospital do Cancer/Fundacio Antonio Prudente in Sao Paulo, Brazil have signed a Memorandum of Understanding, laying the foundation for cooperation to identify specific opportunities and initiatives. Such opportunities would include cooperative programs in research, education, clinical expertise and business opportunities.
The main goals of the partnership will be to:
- develop oncology specific clinical and research educational training programs;
- implement advanced systems for clinical trial management that enhance reporting, bio-statistics and development of study designs;
- collaborate on research projects in the fields of basic and population science;
- and seek joint business ventures.
"This is a unique opportunity, bringing together two of the world's elite cancer research institutions," said Robert C. Young, M.D., president of Fox Chase. "The result of this type of collaboration is the sharing of valuable research information. This relationship could escalate our efforts to better understand cancer, especially in the areas of prevention and treatment."
The Memorandum of Understanding is solely used as the beginning of an expansion of ideas and discussions between the Hospital do Cancer/Fundacio Antonio Prudente and Fox Chase Cancer Center.
Strategic implementations will be facilitated by Philadelphia International Medicine (PIM) with full recognition by Hospital do Cancer that PIM is Fox Chase's international business development partner.
Fox Chase is a founding member of PIM, a consortium of the area's elite institutions. PIM links Greater Philadelphia's nationally recognized hospitals with leading physicians and medical technology to make comprehensive, quality healthcare available to patients in the international community.
Fox Chase Cancer Center is one of 36 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research including prevention, detection and treatment of cancer, and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.